Skip to main
  1. Stocks
  2. DocGo
  3. Forecast
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is supported by a deliberate shift toward higher-quality revenue, as management is exiting or restructuring about $60mm of unprofitable revenue and reducing costs to exit FY26 at a profitable run rate. Its core Mobile Health Services franchise remains the main engine, while Hicuity Health adds $65mm of TTM revenue, $4.5mm of adjusted EBITDA, and about $4.3mm of annual run-rate savings, strengthening the path to positive adjusted EBITDA in FY27. Although CEO turnover, higher leverage, and cash burn create execution risk, the combined platform’s cross-sell opportunity, broad hospital relationships, and stabilizing balance sheet make the long-term fundamental outlook attractive.

Bears say

DocGo is facing a weak fundamental setup because 3Q26 revenue of $73.4mm missed expectations, adjusted EBITDA was negative at ($3.2mm), and mobile health revenue fell 2.5% Y/Y to $20.2mm, showing that its core growth engine is under pressure. Management’s cut to FY26 revenue guidance to about $300mm from $305mm-$310mm, along with higher-than-expected legal, regulatory, and technology spending, signals execution problems and limited operating leverage despite 33.3% gross margins. The balance sheet and cash conversion remain key concerns as the company works through portfolio optimization, with roughly $24.3mm of cash, potential high-cost debt exposure, and a profitability path that still depends on timing-sensitive synergy realization and business-line restructuring.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

DocGo (DCGO) Analyst Forecast & Price Prediction

Get the latest DocGo (DCGO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in DocGo (DCGO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


DocGo (DCGO) Analyst Forecast & Price Prediction

Get the latest DocGo (DCGO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in DocGo (DCGO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover DCGO stock data and trends